or Try an Advanced Search...

    Technical Analysis for PRFX - PainReform Ltd.

    Grade Last Price % Change Price Change
    F 0.85 5.67% 0.05
    PRFX closed up 5.67 percent on Friday, May 17, 2024, on 22 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical PRFX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Outside Day Range Expansion 0.00%
    NR7 Range Contraction 5.67%
    Narrow Range Bar Range Contraction 5.67%
    Narrow Range Bar Range Contraction 5.67%
    NR7 Range Contraction -1.00%
    Narrow Range Bar Range Contraction -1.00%
    Earnings Movers Other -1.00%
    Inside Day Range Contraction -1.00%
    Narrow Range Bar Range Contraction 3.11%
    Older End-of-Day Signals for PRFX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    20 DMA Resistance 1 day ago
    Outside Day 1 day ago
    Up 5% 1 day ago
    Rose Above 20 DMA 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PRFX Chart by TradingView
    Basic chart:

    Profile

    PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug

    Is PRFX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 PainReform reports Q1 results
    May 15 PainReform Provides Business Update for the First Quarter of 2024
    May 8 PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
    Apr 18 PainReform Announces Closing of $4 Million Public Offering
    Apr 16 PainReform prices its $4M offering at $0.80 apiece; shares fall
    Apr 16 PainReform Announces Pricing of $4 Million Public Offering
    Apr 9 PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
    Apr 9 EXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions
    Apr 2 EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug
    Apr 2 PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
    See more PRFX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.41
    52 Week Low 0.69
    Average Volume 177,396
    200-Day Moving Average 2.60
    50-Day Moving Average 1.31
    20-Day Moving Average 0.85
    10-Day Moving Average 0.82
    Average True Range 0.11
    RSI (14) 38.27
    ADX 10.68
    +DI 16.30
    -DI 18.12
    Chandelier Exit (Long, 3 ATRs) 0.64
    Chandelier Exit (Short, 3 ATRs) 1.08
    Upper Bollinger Bands 0.94
    Lower Bollinger Band 0.76
    Percent B (%b) 0.49
    BandWidth 21.14
    MACD Line -0.13
    MACD Signal Line -0.16
    MACD Histogram 0.0331
    Fundamentals Value
    Market Cap 1.71 Million
    Num Shares 2.03 Million
    EPS -6.64
    Price-to-Earnings (P/E) Ratio -0.13
    Price-to-Sales 0.00
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.95
    Resistance 3 (R3) 0.95 0.91 0.93
    Resistance 2 (R2) 0.91 0.88 0.91 0.93
    Resistance 1 (R1) 0.88 0.87 0.89 0.88 0.92
    Pivot Point 0.84 0.84 0.85 0.84 0.84
    Support 1 (S1) 0.81 0.81 0.82 0.81 0.77
    Support 2 (S2) 0.77 0.80 0.77 0.76
    Support 3 (S3) 0.74 0.77 0.76
    Support 4 (S4) 0.74